Fund announced today a total investment of approximately JPY 1 billion (USD 7.3 million1) in four R&D projects for the development of vaccine, drug, and diagnostics for malaria and tuberculosis (TB).2 ...

A new study done by scientists in Switzerland and Sweden investigated the use of automated systems to develop multispecific antibodies.